18F-FDG Brain PET/MRI in Postischemic Hyperperfusion

Faizullah Mashriqi1, James Kim, Ana M Franceschi

  • 1Department of Radiology, Neuroradiology Division, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Lenox Hill Hospital, New York, NY.

PubMed

Insights

This study details a stroke patient experiencing memory issues. Brain imaging revealed focal hypermetabolism in infarct areas, identified as luxury perfusion, not neurodegeneration.

Area of Science:

  • Neurology
  • Neuroimaging
  • Stroke Medicine

Background:

  • A 58-year-old male with a history of myocardial infarction and ventricular thrombus presented with recurrent stroke symptoms.
  • Initial symptoms included left arm weakness, followed by dysarthria and right-sided weakness, indicating cerebrovascular events.

Purpose of the Study:

  • To investigate the cause of impaired memory in a stroke patient that was not explained by ischemic areas.
  • To differentiate between neurodegenerative disease and other causes of cognitive impairment using advanced neuroimaging.

Main Methods:

  • Structural imaging (CT/MRI) was used to identify acute/subacute ischemic stroke locations in the right frontal and parietal lobes.
  • 18F-FDG brain PET/MRI was performed to evaluate for neurodegenerative disease and assess metabolic activity in brain regions.

Main Results:

  • Structural imaging confirmed ischemic strokes in the right frontal and parietal lobes.
  • 18F-FDG brain PET/MRI ruled out neurodegenerative disease.
  • Focal hypermetabolism was observed in the acute/subacute infarct areas, consistent with luxury perfusion (postischemic hyperperfusion).

Conclusions:

  • The patient's memory impairment was attributed to luxury perfusion in the infarct areas, not a primary neurodegenerative process.
  • 18F-FDG brain PET/MRI is a valuable tool for differentiating post-stroke hyperperfusion from neurodegeneration in cognitive impairment workups.